Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Constella Group to partner with TCG Lifesciences
August 2007
SHARING OPTIONS:

DURHAM, N.C.Constella Group, a global provider of professional health services, announced that it entered into a partnership with TCG Lifesciences, an India-based contract drug discovery and drug development company. As part of the non-exclusive relationship, Constella and TCG Lifesciences will jointly promote their contract services and identify and promote business opportunities across the two organizations.
 
Working with TCG Lifesciences' clinical research and development arm (ClinInvent), Constella will promote ClinInvent's clinical services to its clients interested in conducting clinical studies in India. In return, TCG Lifesciences will use its contacts in the expanding Indian biotechnology and pharmaceutical markets to promote Constella's services in Europe and the United States. Constella and TCG Lifesciences will work together to explore market opportunities in India for training, quality assurance and regulatory affairs services.
 
"India is attractive...because of the rapid patient recruitment into clinical studies and the country's highly skilled workforce. This partnership allows us to expand our services into new areas of the world." says Donald A. Holzworth, Constella Group chairman and CEO.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.